BMJ Best Practice vs ESC CVD Risk Calculation

Instant access to the latest evidence-based guidance for healthcare professionals. Updated daily, BMJ Best Practice provides healthcare professionals with the latest evidence-based clinical decision support information. It's available offline, which means clinical decision support can be accessed anytime, anywhere. This app can be downloaded by those who have access to the BMJ Best Practice website, and have already set-up a username and password. Don’t have a subscription? Download the app and access a free 7 day trial. The app provides: - Fast access to the latest guidance on diagnosis, prognosis, treatment and prevention - 500+ patient leaflets - 250+ medical calculators - Guidance videos on common clinical procedures - Automatic CME/CPD activity tracking Your feedback helps to inform future developments. At BMJ, we have a user-centered product development process, which means that we enhance the product based on what our customers, and our users tell us they need and want. As a result, we have introduced features such as ‘night mode’ and patient leaflets to the app. If you have a question or want to provide feedback, please contact us at support@bmj.com. Thank you!

The ESC CVD Risk Calculation App is designed for healthcare professionals. It provides calculators assessing individual cardiovascular risk. It includes calculators for primary and secondary prevention in various populations: 1. SCORE2 2. SCORE2-OP 3. SCORE2-Diabetes 4. ASCVD 5. SMART 6. SMART-REACH* 7. DIAL* 8. LIFE-CVD* * Available online on U-Prevent (Internet connection required) The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App. This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance. This Application is powered by the European Society of Cardiology (ESC), based upon the source codes of the U-Prevent webtool, a concept developed by University Medical Center Utrecht, redesigned and owned by ORTEC. The SCORE2, SCORE2-OP and SCORE2-Diabetes calculators were developed in collaboration with the ESC Cardiovascular Risk Collaboration unit. The Application has recently been updated in the framework of the EAPC IMPLEMENT Programme (2023) which was supported by Novo Nordisk in the form of an educational grant. The sponsor did not have any involvement or influence on the features nor on the scientific content within the Application.